The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines

Arnold S Monto1, Maria Zambon1, Jerry P Weir1

  • 1From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).

Abstract

No abstract available in PubMed .